학술논문
Bortezomib-based induction, high-dose melphalan and lenalidomide maintenance in myeloma up to 70 years of age
Document Type
Article
Author
Mai, E.K.; Bertsch, U.; Merz, M.; Hose, D.; Seckinger, A.; Sauer, S.; Raab, M.S.; Goldschmidt, H.; Miah, K.; Kunz, C.; Benner, A.; Dürig, J.; Scheid, C.; Weisel, K.C.; Munder, M.; Lindemann, H.-W.; Jauch, A.; Luntz, S.; Fuhrmann, S.; Brossart, P.; Elmaagacli, A.; Goerner, M.; Bernhard, H.; Hoffmann, M.; Blau, I.W.; Hänel, M.; Salwender, H.J.
Source
In: Leukemia . (Leukemia, March 2021, 35(3):809-822)
Subject
Language
English
ISSN
14765551
08876924
08876924